Literature DB >> 25733348

Oxidative stress and mechanisms of ochronosis in alkaptonuria.

Daniela Braconi1, Lia Millucci1, Giulia Bernardini1, Annalisa Santucci2.   

Abstract

Alkaptonuria (AKU) is a rare metabolic disease due to a deficient activity of the enzyme homogentisate 1,2-dioxygenase (HGD), involved in Phe and Tyr catabolism. Due to such a deficiency, AKU patients undergo accumulation of the metabolite homogentisic acid (HGA), which is prone to oxidation/polymerization reactions causing the production of a melanin-like pigment. Once the pigment is deposited onto connective tissues (mainly in joints, spine, and cardiac valves), a classical bluish-brown discoloration is imparted, leading to a phenomenon known as "ochronosis", the hallmark of AKU. A clarification of the molecular mechanisms for the production and deposition of the ochronotic pigment in AKU started only recently with a range of in vitro and ex vivo human models used for the study of HGA-induced effects. Thanks to redox-proteomic analyses, it was found that HGA could induce significant oxidation of a number of serum and chondrocyte proteins. Further investigations allowed highlighting how HGA-induced proteome alteration, lipid peroxidation, thiol depletion, and amyloid production could contribute to oxidative stress generation and protein oxidation in AKU. This review briefly summarizes the most recent findings on HGA-induced oxidative stress in AKU, helping in the clarification of the molecular mechanisms of ochronosis and potentially providing the basis for its pharmacological treatment. Future work should be undertaken in order to validate in vivo the results so far obtained in in vitro AKU models.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid; Homogentisic acid; Lipid peroxidation; Protein carbonyls; Proteomics; Redox proteomics; Serum amyloid A; Thiol oxidation

Mesh:

Substances:

Year:  2015        PMID: 25733348     DOI: 10.1016/j.freeradbiomed.2015.02.021

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  17 in total

1.  A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.

Authors:  J B Mistry; D J Jackson; M Bukhari; A M Taylor
Journal:  Clin Rheumatol       Date:  2015-10-16       Impact factor: 2.980

2.  Fatal methemoglobinemia complicating alkaptonuria (ochronosis): a rare presentation.

Authors:  Amanda R Freeman; Stephen M Wills
Journal:  Forensic Sci Med Pathol       Date:  2018-03-23       Impact factor: 2.007

3.  Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients.

Authors:  Mohammad S Z Ahmad; Mahmoud Ahmed; Milad Khedr; Alfredo Borgia; Andrea Madden; Lakshminarayan R Ranganath; Stephen Kaye
Journal:  JIMD Rep       Date:  2022-04-09

Review 4.  Acute fatal metabolic complications in alkaptonuria.

Authors:  A S Davison; A M Milan; J A Gallagher; L R Ranganath
Journal:  J Inherit Metab Dis       Date:  2015-11-23       Impact factor: 4.982

Review 5.  Amyloidosis in alkaptonuria.

Authors:  Lia Millucci; Daniela Braconi; Giulia Bernardini; Pietro Lupetti; Josef Rovensky; Lakshminaryan Ranganath; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2015-04-14       Impact factor: 4.982

6.  Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease.

Authors:  Vittoria Cicaloni; Ottavia Spiga; Giovanna Maria Dimitri; Rebecca Maiocchi; Lia Millucci; Daniela Giustarini; Giulia Bernardini; Andrea Bernini; Barbara Marzocchi; Daniela Braconi; Annalisa Santucci
Journal:  FASEB J       Date:  2019-08-28       Impact factor: 5.834

7.  Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria.

Authors:  Stephen D Thorpe; Silvia Gambassi; Clare L Thompson; Charmilie Chandrakumar; Annalisa Santucci; Martin M Knight
Journal:  J Cell Physiol       Date:  2017-03-31       Impact factor: 6.384

8.  Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC-QTOF-MS.

Authors:  Andrew S Davison; Brendan P Norman; Gordon A Ross; Andrew T Hughes; Milad Khedr; Anna M Milan; James A Gallagher; Lakshminarayan R Ranganath
Journal:  JIMD Rep       Date:  2019-05-31

9.  Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria - Is nitisinone the solution?

Authors:  A S Davison; E Luangrath; E Selvi; L R Ranganath
Journal:  Mol Genet Metab Rep       Date:  2020-04-16

10.  Enhanced Protocatechuic Acid Production From Glucose Using Pseudomonas putida 3-Dehydroshikimate Dehydratase Expressed in a Phenylalanine-Overproducing Mutant of Escherichia coli.

Authors:  Oliver Englund Örn; Stefano Sacchetto; Ed W J van Niel; Rajni Hatti-Kaul
Journal:  Front Bioeng Biotechnol       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.